Mechanism of action of brexpiprazole: comparison with aripiprazole

Stephen M. Stahl
2016 CNS Spectrums  
Brexpiprazole is a new therapeutic agent that was recently approved for the treatment of schizophrenia and for the adjunctive treatment of major depressive disorder. Brexpiprazole has features that both overlap and contrast with a related molecule, aripiprazole, and these features are discussed here.
doi:10.1017/s1092852915000954 pmid:26899451 fatcat:jevjbvz6fvdtlcmwzmx3pkmn2m